Amytrx Therapeutics

About:

Amytrx Therapeutics is a biopharmaceutical company that advances the next generation of new anti-inflammatory peptide therapies.

Website: https://www.amytrx.com/

Description:

Amytrx Therapeutics is a biopharmaceutical company that advances the next generation of new anti-inflammatory peptide therapies for patients with chronic inflammatory diseases. The company's AMTX-100 is bioengineered using human protein sequences that modulate the immune system by a natural process. Amytrx Therapeutics was founded in 2014 by Matthew A. Gonda and is based in Nashville, Tennessee.

Total Funding Amount:

$29M

Headquarters Location:

Nashville, Tennessee, United States

Founded Date:

2014-01-01

Contact Email:

contact(AT)amytrx.com

Founders:

Matthew Gonda

Number of Employees:

1-10

Last Funding Date:

2022-05-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai